Glenmark Pharmaceuticals wins ‘India Pharma Innovation of the Year’ award

27 Apr 2022 Evaluate

Glenmark Pharmaceuticals has received the ‘India Pharma Innovation of the Year’ award and was adjudged runners-up in the ‘India Pharma CSR of the Year’ category, as part of the India Pharma & India Medical Device Awards 2022. The seventh edition of the annual awards was jointly organized by the Department of Pharmaceuticals, Ministry of Chemicals & Fertilizers, The Federation of Indian Chambers of Commerce & Industry (FICCI) and Invest India.

The award recognizes Glenmark’s multiple patents and innovations in its core therapy areas of Dermatology, Respiratory and Oncology, over the last three years. It also acknowledges the Company’s contribution to the healthcare sector, in meeting both pressing and long-term patient needs.

The company has previously won awards from the Dept. of Pharmaceuticals under the categories of India Pharma Leader Award (2015), Company of the Year (2016), Corporate Social Responsibility Program of the Year (2017) and ‘Indian Pharma Innovation of the year’ (2021). 

Glenmark Pharmaceuticals is a global research-led pharmaceutical company with presence across Generics, Specialty and OTC business with operations in over 50 countries.

Glenmark Pharma Share Price

1248.65 -17.05 (-1.35%)
02-Jul-2024 16:01 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1522.45
Dr. Reddys Lab 6368.50
Cipla 1487.75
Zydus Lifesciences 1070.35
Lupin 1633.10
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.